Neuron23 Funding & Investors
South San Francisco, CA
Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases.
neuron23.comTotal Amount Raised: $213,500,000
Neuron23 Funding Rounds
Series C
$100,000,000
Series C Investors
SoftBank Vision FundHBM Healthcare InvestmentsWestlake Village BioPartnersKleiner PerkinsHBM PartnersRedmile GroupPerceptive AdvisorsAcorn BioventuresCowenSurveyor CapitalSeries A
$33,500,000
Series A Investors
Kleiner PerkinsWestlake Village BioPartnersSeries B
$80,000,000
Series B Investors
Redmile GroupSurveyor CapitalCowenAcorn BioventuresHBM PartnersKleiner PerkinsWestlake Village BioPartnersPerceptive AdvisorsHBM Healthcare Investments
Funding info provided by Diffbot.